A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD

Summary

A Multicenter, Randomized, Double-blind, Single-dummy, positive drug and placebo-controlled, Parallel Group, Phase 2a Study to Evaluate the Efficacy and Safety of Hemay005 in Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start

2026-01-01

Primary completion

2027-12-31

Completion

2027-12-31

Drugs

Indications